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The study of immune responses inDrosophilahas already yielded significant results with impacts on our understanding of vertebrate
immunity, such as the characterization of the Toll receptor. Several recent papers have focused on the humoral response to
damage signals rather than pathogens, particularly damage signals from tumour-like tissues generated by loss of cell polarity or
chromosomal instability. Both the triggers that generate this sterile inflammation and the systemic and local effects of it are only
just beginning to be characterized in Drosophila. Here we review the molecular mechanisms that are known that give rise to the
recruitment ofDrosophila phagocytes, called hemocytes, as well as the signals, such as TNF𝛼, that stimulated hemocytes emit at sites
of perceived damage. The signalling consequences of inflammation, such as the activation of JNK, and the potential for modifying
this response are also discussed.
1. Introduction
The inflammatory response to infection by pathogens has
been intensively studied for many years both in humans and
in all the major model organisms. More recently, there has
been increasing interest in understanding the situations in
which inflammation arises without an external pathogen [1].
These include almost any stimulus that gives tissue damage,
such as burns, as well as autoimmune disease, atherosclerosis,
stroke, and cancer.Themolecular details of these self-induced
inflammatory responses are now becoming clearer, though
there appears to be a wide variety of triggers and outcomes
that range from beneficial to lethal [2]. To make sense of the
complexity and sort out causes from effects, model organisms
amenable to geneticmanipulation can be extremely useful. In
this review we will focus on recent progress in understanding
the causes and effects of sterile inflammation in Drosophila,
which has many advantages for this kind of work.
The immune system in Drosophila is relatively simple:
they lack adaptive immunity but have a robust innate immune
system that has many functional and molecular similarities
to that of vertebrates [3]. The immune cells in flies are
collectively described as hemocytes; in normal animals they
consist primarily of plasmatocytes with a phagocytic role
as well as some crystal cells for melanization and clotting
[4, 5].The humoral innate immune response includes several
antimicrobial peptides (AMPs), which can be produced from
most epithelia, and upon infection are generated at high
levels from the fat body, the equivalent of the vertebrate liver
[6]. In addition there are a range of extracellular signalling
molecules that are used to identify the presence of pathogens
and trigger an inflammatory response [5]. These triggers
include well known factors such as components of bacterial
cell walls but also less well understood mechanisms such
as an extracellular protease cleavage cascade that results in
the activation of the IL-1R-like receptor Toll and the NF𝜅B
pathway. Although the inflammatory response in Drosophila
lacks several features of vertebrate inflammation, such as heat,
redness, and extravasation of leucocytes, some signalling
pathways regulating the response are conserved and indeed
were discovered in Drosophila. In both insects and mammals
there is the recruitment of immune cells to the affected
site and the release of chemicals and peptides intended to
damage pathogens; this is the process we are describing as
inflammation.
It has become clear that, in the case of sterile inflamma-
tion, although there is no pathogen present, the inflammatory
response is often similar to that seen in infection, and many
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of the same pathways are used [1, 5]. The inflammatory
triggers, however, are not from a pathogen and must be
generated by changes to normal cells that expose altered
or mislocalized self-molecules to the immune system to
generate a damage signal. These signals, known as damage-
associated molecular patterns (DAMPs), are currently the
subject of intensive research and may include extracellular
chromatin, ATP, cytoskeletal molecules, and mitochondrial
components [2]. In vertebrates, these are detected by diverse
receptors including the many Toll-like receptors (Tlrs), but
in flies the situation is likely to be less complex. In the next
section we will examine the types of cellular damage that
can give rise to sterile inflammation during larval life in
Drosophila and the molecular triggers involved.
2. Sources of Sterile Inflammation
Triggers in Drosophila
Many DAMPs are the normal molecules of the cytoplasm
or nucleus that become immunogenic when exposed to
extracellular environment. For example, in case of necrosis,
nuclear or mitochondrial DNA is released into the extra-
cellular environment and acts as a DAMP. Other DAMPs
identified in vertebrates include high mobility group box
1 (HMGB1), reactive oxygen species (ROS), cytoskeletal
molecules, nucleotides (e.g., ATP) and nucleosides (e.g.,
adenosine), uric acid, phosphatidylserine (PS), heat shock
proteins (HSPs), hyaluronan, heparan, syndecan, and proba-
bly others which are still unidentified [2]. Some of them (e.g.,
nucleotides) are conserved between species and also shared
by all types of tissue injuries [7].
2.1. Necrotic Cells. Necrosis is the main source of damage
signals in many tissue injuries such as tumours, thermal
effects, mechanical trauma, ischemia, hypoxia, and apop-
tosis-mutants. Acidification and the oxidative environment
of necrotic cells are thought to cause proinflammatory
changes to DAMPs inside and out of the cell. For example,
high mobility group box-1 (HMGB1) is a nonhistone, DNA
binding protein that has been implicated as a DAMP in
vertebrates [2, 8]. As a result of ROS, partially oxidised
HMGB1 is released out of the necrotic cells and binds to
extracellular mediators of inflammation (such as ssDNA
or lipopolysaccharides) and promotes activation of Toll-
like receptors [9]. This mechanism has not been studied in
detail in Drosophila, but we have found that loss of HMGB1
reduces sterile inflammation (our unpublished results). The
release of DNA from necrotic cells may also contribute to
a conserved inflammatory response, as Drosophila mutants
that block DNAseII function show a humoral response [10]
with similarities to vertebrate signalling [11].
Reactive oxygen species are also released from necrotic
cells in Drosophila and act as an immediate damage signal
which may trigger the recruitment of hemocytes to the
injured tissue [12–14]. ROS and TNF𝛼 (Eiger) released
from necrotic neuronal cells can trigger JNK activation in
surrounding cells [12]. The activated JNK pathway triggers
apoptosis, hemocyte recruitment, andwound healing [12, 15].
This occurs at least partly by activation of matrix metallo-
proteinases (MMPs) which can result in the production of
DAMPs by digesting basement membrane [16, 17], though
their primary function is one of repair [18]. TNF𝛼, phos-
phatidylserine (PS), and other DAMPs have been shown to
enhance the activation of the prophenoloxidase activating
system (PAS) at the site of injury. Activation of the PAS
melanizes wound clots and other encapsulated tissues or
pathogens [19], as well as triggering a systemic response [20].
2.2. UndeadCells. Undead cells, such as cells that fail to apop-
tose due to caspase mutations [21], are known to promote
the activation of the extracellular protease Persephone as a
trigger of the innate immune response [22, 23]. Persephone
acts as a sensor in the hemolymph, which informs the insect
about the presence of stress, damage, or pathogens [24]. The
trigger for Persephone in sterile inflammation is not known,
but we speculate that the release of necrotic material (e.g.,
intracellular proteases) can trigger activation of Persephone
and the cleavage cascade that produces a systemic immune
response [3, 5, 6, 22]. For example, it is known that some
soluble DAMP in the hemolymph is required for the systemic
immune response seen in apoptosismutants [22]. Restraining
the systemic activation of the immune proteases are serpins
such asNecrotic, which is expressed ubiquitously and helps in
establishing a localized signal gradient at the site of damage
by damping the overall proteolytic activity in the body. This
localization of the signal assists the recruitment of hemocytes
[19].
2.3. Wounds. Wounding, in a nonpathogenic environment,
promotes a similar activation of the immune response as
described above, because wounds contain both necrotic and
stressed cells. Sterile wounding in Drosophila is thought to
stimulate the pathogen response as a protective measure
against expected infection [25, 26], though, at least in adults,
the intensity of the response may be less than that for an
infection [27]. In sterile wounding, release of DAMPs at
the wound site has been proposed to result in activation of
Persephone and differentiation of lamellocytes from precur-
sor hemocytes [4, 5, 24, 28]. Lamellocytes are involved in the
encapsulation of target tissue (normally degenerating tissues
and oversized pathogenic invaders) and then in melanizing
them via activation of the phenoloxidase cascade. Basement
membrane (BM) disruption acts as a trigger for the immune
response in wound regions as well as metastasizing tumors
[16, 29, 30]. Laminin is a major component of the BM which
acts as a checkpoint for self/nonself and normal/damaged
tissue. It acts as an inhibitory ligand for hemocytes [17, 31]
and is also important for cell integrity. Cell integrity (cell-cell
adhesion and apicobasal polarity) of self-tissues also acts as a
determinant for the immune response. Loss of both BM and
cell integrity is required to target an otherwise self-tissue for
encapsulation by lamellocytes [17].
2.4. Tumors. Tumor interactions with the immune system
are typically required for their growth and metastasis [4].
Tumour growth generates signals that have been linked
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to hemocyte proliferation and recruitment [32–34]. In
Drosophila, tumor cells activate TNF𝛼, Pvf/Pvr, and the
Toll pathway to trigger the systemic immune response (see
below). The loss of apicobasal cell polarity often seen in
malignant outgrowth also induces recruitment of hemocytes
and encapsulation [33]. Triggering mechanisms have not
been explored in detail, but expression of an oncogene
(RasV12) in Drosophila showed hyperplastic growth and
increased expression of metalloproteinases [34, 35]. This is
relevant because increased expression ofMMPs causes degra-
dation of basement membrane, which leads to inflammation
[16, 34]. In addition, exposure of phosphatidylserine on the
surface of RasV12 mutant cells [34] can trigger the prophe-
noloxidase activating system which gives melanisation and
encapsulation [19].
Finally, cancer cells often exhibit a high rate of genetic
change due to chromosomal instability (CIN). CIN can
provide variability and adaptability but at the cost of gen-
erating ROS and cellular stress which often results in cell
death [36, 37]. Release of cellular debris from CIN tissue
gives both localized and systemic activation of the Toll
pathway (our unpublished data). CIN also leads to DNA
damage [36–38]. Unrepaired DNA damage in Drosophila
elicits an innate immune response which leads to systemic
activation of JAK/STAT signaling, hemocyte proliferation,
and melanization [16, 39, 40].
3. Effects of the Inflammatory Response
Inflammation in Drosophila typically results in the pro-
duction of antimicrobial peptides and the recruitment of
hemocytes [4, 5, 41]. Antimicrobial peptides are not known
to have strong effects on the organism in the absence of a
pathogen, though they can potentially affect neural tissue [42]
and promote autoimmunity [43]. Recruitment of hemocytes,
on the other hand, has profound implications for the tissue
involved as well as for the animal as a whole.
A population of hemocytes constantly circulates in the
haemolymph, having access to the basal surface of most
organs and tissues. As described above, there are a number of
signals released by damaged or aberrant tissues that lead to
the accumulation of hemocytes at the site, in a process that is
thought to involve capture of passing hemocytes rather than
active migration, at least in the larva [29]. In a sterile wound,
both plasmatocytes and crystal cells gather, degranulating
to release clotting factors as well as a range of signalling
molecules [5]. These signals include the TNF𝛼 homolog
Eiger and the cytokines Unpaired-3 and Spaetzle (Figure 1),
showing clear similarity to vertebrate sterile inflammation
[2].
3.1. Cytokine Signaling. The production of the NGF𝛽
homolog Spaetzle [44] by hemocytes is primarily thought
to drive systemic rather than local immune responses in
Drosophila. For example, activation of the Spaetzle receptor
Toll just in hemocytes does not improve immune responses
[45]. Instead, the principal immune effect of the Spaetzle
signal is seen in the fat body [33], equivalent to the vertebrate
liver, which responds by becoming the primary source of
antimicrobial peptides [46, 47]. Recent work has shown, in
response to tissue dysplasia, that Spaetzle activating Toll in
the fat body is also needed to drive TNF𝛼mediated cell death
in the aberrant tissue [33]. Spaetzle is a highly regulated
signal, being secreted as a proprotein that requires protease
cleavage in order to be active. A wide range of extracellular
proteases that are either produced by bacteria or activated
by bacterial molecules are known to generate active cleaved
Spaetzle during infections [5]. In sterile inflammation,
activation of the protease Persephone is probably required
[22, 23], though how it is regulated is not known. We
speculate that the same necrotic cell death that attracts
hemocytes can release normally intracellular proteases that
trigger Persephone and the cleavage cascade that produces
active Spaetzle.Themolecular pathway by which the Spaetzle
receptor Toll activates the humoral immune response has
been analysed in detail and closely parallels the vertebrate
pathway [3, 5, 6]. Still relatively unknown, however, are
the transcriptional outputs of this pathway in response to
DAMPs, beyond a handful of antimicrobial peptides. We
do not know, for example, what targets of NF𝜅B might be
relevant for the fat body and Toll-dependent death of tumour
tissue [33]. Presumably this is mediated by the fat body
signalling to increase the release of TNF𝛼 on the tumour by
hemocytes, but the molecules used are not known. Spaetzle
is also implicated in cell competition, where it activates
signalling via Toll-like receptors to kill relatively unfit cells
[48]. The source of Spz and the involvement of hemocytes in
this process have not yet been determined.
Hemocytes also release the IL-6 related cytokine Un-
paired-3, which is produced in a feedback response to
Unpaired signalling from wounds or tumours [16]. Damaged
tissue activates the JNK pathway which increases the tran-
scription of Unpaired, Unpaired-2, and Unpaired-3, which
are secreted by the tissue to activate JAK/STAT signalling
in hemocytes that have been recruited, as well as from
the fat body. JAK/STAT signalling produces more hemocyte
secretion of the Unpaired cytokines in a positive feedback
loop as well as driving hemocyte proliferation and lamel-
locyte differentiation [49].This system resembles a simplified
version of the mammalian use of interleukins and JAK/STAT
signalling in inflammatory responses [50].
3.2. Tumor Necrosis Factor Signalling. While Spaetzle and
Unpaired have systemic effects on hemocyte numbers, the
primary effector molecule secreted by hemocytes in sterile
inflammation is TNF𝛼 (Eiger) [51, 52]. TNF𝛼 is clearly
secreted by hemocytes that have been recruited to sites of
cellular damage [33] and possibly also by unstimulated hemo-
cytes [53, 54]. TNF𝛼 signalling through the TNF receptor
Wengen has two well described effects: activation of JNK
signalling and cell death [52]. Strong and persistent activation
of JNK leads to increased transcription of the proapoptotic
genes hid and reaper [55], which TNF𝛼 also activates by a
parallel pathway involving the TRIP homolog Nopo [56].
Consequently, cell death is a significant feature of normal
inflammatory responses in Drosophila larvae. However, it




















Figure 1: Tumors appear as damaged tissue, releasing DAMPS including ROS and triggers that recruit hemocytes and activate the proteolytic
cascade that results in the production of active Spaetzle (Spz). Spz acts both locally and in the fat body to stimulate signalling through
Toll/NF𝜅B. Hemocytes also release the short-range signal TNF𝛼 which, along with Toll signalling, activates JNK in the target tissue. JNK
signalling produces cytokines like Pvf1, degrades basement membrane via matrix metalloproteases (MMP1), and promotes apoptosis. All
these effects tend to recruit and activate further hemocytes at the damage site to generate an effective inflammatory response.
is important to bear in mind that JNK also has many
other functions [57], so, for example, if its apoptotic role is
blocked, Eiger-JNK signaling can contribute to proliferation
and metastasis [58–60]. Furthermore, JNK signalling can be
protective in neural tissue, and this ROS-mediated protection
by JNK activation is needed to survive even sterile wounds
[20].
It is interesting to consider what constitutes the targeting
signal of the innate immune response. Hemocytes, as the
primary detectors of damage or pathogens, release active
Spaetzle to give systemicToll activation andUnpaired to drive
hemocyte proliferation, but this does not explain how the
response is focused on the site of infection/damage [53]. It
appears that hemocyte recruitment and retention is essen-
tial to localize the response. Reacting to the as-yet poorly
defined damage signals, hemocytes potentially reinforce their
localization by generating more local damage. The release
of TNF𝛼 causes cell death as well as JNK activation, which
drives the secretion of basement membrane proteases such
asMMP1, which is sufficient to generate hemocyte-localizing
damage, as described above. Furthermore, we have found that
local activation of Toll in the target tissue is essential for the
normal apoptotic response. In this case, signalling through
Toll/NF𝜅B in defective tissue activates JNK to produce
MMP1 and recruit hemocytes (our unpublished data). This
constitutes a local amplification loop perhaps resembling the
vertebrate Toll-like receptor p75 that drives both NF𝜅B and
JNK [52].
3.3. Reactive Oxygen Species. The role of reactive oxy-
gen species in sterile inflammation is still unclear, though
undoubtedly significant. Several ROS molecules have been
implicated in antibacterial responses [3, 61] and in these
cases they are typically generated to damage pathogens but
also to stimulate hemocytes to generate a systemic response
[62]. Less is known about how ROS might act in sterile
inflammation: they can be produced by TNF𝛼 signalling
and contribute to the resulting cell death [63], and they act
with or without growth signals to activate JNK signalling in
different tissues [20, 64]. The hydrogen peroxide produced
by damaged tissue is necessary, at least inDrosophila embryos
and zebrafish, for the recruitment of hemocytes or leukocytes
[14, 65]. These studies implicate the calcium flash from
wounding in triggering activation of the peroxide-generating
enzyme DUOX to generate the ROS signal for attracting
hemocytes. However, metabolic disruption in tumours or
chromosomal instability also produces ROS [36, 66], so the
same ROS signal may also be used in the absence of external
wounding. As a damage signal, hydrogen peroxide has many
advantages: it is readily produced by defective cells, it diffuses
through membranes, and it is reactive enough to limit its
own diffusion to a few cell diameters [67]. Following the
recruitment of hemocytes to an inflammatory site, we expect
that the production of TNF𝛼 by the hemocytes [33] increases
ROS production in nearby cells [63, 68], as yet another
positive feedback loop to encourage the death of damaged
cells.
ROS production is strongly affected by a range of
metabolic controls that are altered by inflammation [3]. In
Drosophila this may be mediated by the fat body, which
responds to necrosis by activating JNK targets such as FOXO
that both increase antioxidant production and drive lipolysis,
the normal response to starvation [21]. This energy wasting
effect is commonly seen in both infections and cancer in all
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organisms, leading to cachexia that has been associated with
elevated TNF levels and may respond to anti-inflammatory
therapy [69].
4. Implications of Sterile
Inflammation Control
It is perhaps surprising that the inflammatory response that
is used to clear bacterial infections and to clot wounds
should cause hemocytes to secrete TNF𝛼, which damages
the host more than the pathogen. Unwanted TNF𝛼 can be
responsible for debilitating disease, as seen in allergies and
autoimmune diseases that respond strongly to anti-TNF𝛼
therapies. Nonetheless, TNF𝛼 is a valuable protective mech-
anism, as TNF𝛼 inhibitor therapy in humans is associated
with increased risk of infections and, significantly, cancer
[70]. Experiments in Drosophila have underlined the need
for localised TNF𝛼 production by hemocytes to control the
growth of neoplastic tissue [16, 33]. In this context it is
worth noting that loss of neutrophils, which share some
features with hemocytes, is still an extremely common but
obviously undesirable side effect of the front-line human
chemotherapies [71]. Not only does neutropenia leave the
patient vulnerable to infection, but also reduces the body’s
innate immune response to cancer.
While T-cell based immunotherapies are now avail-
able [72], effective cancer treatments using innate immune
responses have not been developed. This may be partly
because tumours must have typically developed some resis-
tance to the innate immune response to have survived and
grown to a point where they can be detected [7]. At this
point the tumour may well be dependent on proinflamma-
tory signalling, so therapies have been developed instead
to combat inflammatory signalling. This stage of tumour
development has been modelled in Drosophila by expression
of active Ras, which can be used to generate tumours that
depend on TNF𝛼 for invasive outgrowth [54]. These results
underline the key role of JNK in modulating outcomes: the
innate immune response can activate JNK signalling to kill
damaged or infected tissue, but, in cases where cell death is
blocked, the same signal promotes outgrowth and prolifera-
tion [55, 57, 60]. Clearly caution is needed in any intervention
that alters the level of inflammatory response in either
direction.
As this review has indicated, there is still a great deal
that is unknown about the mechanisms that regulate sterile
inflammation. Many inflammatory triggers from damaged
tissue are yet to be characterized, particularly in model
organisms. Similarly, we know little about the mechanisms
that damp the many positive feedback systems to prevent a
life-threatening excessive response to tissue damage. How-
ever, the signalling pathways and cytokines that mediate
inflammation are now becoming relatively well studied
and amenable to analysis by the mutagenesis screening
approaches that have made Drosophila such a valuable tool
[73]. With the current intense activity in the field we expect
significant improvements in our understanding of sterile
inflammation in the near future.
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